Description
Retatrutide 10 mg research overview
Retatrutide triple agonist research peptide for GLP-1, GIP and glucagon pathway models. COA supplied. RUO.
Retatrutide is a triple GLP-1, GIP and glucagon receptor agonist reference peptide for multi-incretin metabolic research.
Peptide Shop supplies Retatrutide 10 mg as a sealed research material with lot-level documentation where available. This product is supplied for in-vitro laboratory research only and is not intended for human or veterinary diagnostic, therapeutic, cosmetic or consumption purposes.
Research use
- Triple-receptor agonism and metabolic signalling
- Energy-expenditure and glucose-regulation models
- Comparative studies against single and dual incretin agonists
Position within diabetes and weight-loss research clusters for internal linking.
Sequence and analytical data
| Field | Detail |
|---|---|
| Product ID | peptide-retatrutide |
| Package size | 1 × 5 mg vial |
| CAS number | 2381089-83-2 |
| Molecular weight | 4156.48 g/mol |
| Purity | ≥ 99% |
| Storage | -20°C recommended (research-only) |
Batch-specific documentation may include HPLC purity, identity confirmation and lot information. Refer to the supplied COA or the COA policy for current documentation scope.
Reconstitution and handling
Allow lyophilised material to equilibrate before opening to reduce condensation risk. Add validated solvent slowly down the vial wall, avoid vigorous shaking, and record the final concentration in the laboratory notebook or LIMS.
Use aseptic technique, calibrated pipettes or syringes, and validated diluent choices for the assay system. Reconstituted materials should be aliquoted where appropriate to reduce repeated freeze-thaw exposure.
Storage
Store unopened material according to the stated condition: -20°C recommended (research-only). Keep vials sealed, dry and protected from light. Reconstituted solutions should be stored under validated laboratory conditions and discarded according to internal SOPs and applicable research-waste rules.
Related resources
Research-use statement
Retatrutide 10 mg is sold by Peptide Shop for research use only. It is not a medicine, food, cosmetic, supplement or diagnostic product. Buyers are responsible for ensuring lawful purchase, storage, handling and disposal under their institutional and local requirements.
References
- Jastreboff AM et al. “Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial.” N Engl J Med. 2023;389(6):514–526. PMID 37506189
- Rosenstock J et al. “Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA.” Lancet. 2023;402(10401):529–544. PMID 37506190
- Coskun T et al. “LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept.” Cell Metab. 2022;34(9):1234–1247.e9. PMID 36070795
